Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1996 1
1997 2
1998 4
2000 2
2001 2
2003 2
2004 3
2005 3
2006 8
2007 8
2008 8
2009 6
2010 6
2011 6
2012 9
2013 9
2014 10
2015 5
2016 7
2017 7
2018 11
2019 9
2020 8
2021 6
2022 7
2023 8
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, Li D, Verret W, Xu DZ, Hernandez S, Liu J, Huang C, Mulla S, Wang Y, Lim HY, Zhu AX, Cheng AL; IMbrave150 Investigators. Finn RS, et al. N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745. N Engl J Med. 2020. PMID: 32402160 Clinical Trial.
Challenges in glioblastoma research: focus on the tumor microenvironment.
Bikfalvi A, da Costa CA, Avril T, Barnier JV, Bauchet L, Brisson L, Cartron PF, Castel H, Chevet E, Chneiweiss H, Clavreul A, Constantin B, Coronas V, Daubon T, Dontenwill M, Ducray F, Enz-Werle N, Figarella-Branger D, Fournier I, Frenel JS, Gabut M, Galli T, Gavard J, Huberfeld G, Hugnot JP, Idbaih A, Junier MP, Mathivet T, Menei P, Meyronet D, Mirjolet C, Morin F, Mosser J, Moyal EC, Rousseau V, Salzet M, Sanson M, Seano G, Tabouret E, Tchoghandjian A, Turchi L, Vallette FM, Vats S, Verreault M, Virolle T. Bikfalvi A, et al. Among authors: castel h. Trends Cancer. 2023 Jan;9(1):9-27. doi: 10.1016/j.trecan.2022.09.005. Epub 2022 Nov 16. Trends Cancer. 2023. PMID: 36400694 Review.
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Sangro B, Chan SL, Kelley RK, Lau G, Kudo M, Sukeepaisarnjaroen W, Yarchoan M, De Toni EN, Furuse J, Kang YK, Galle PR, Rimassa L, Heurgué A, Tam VC, Van Dao T, Thungappa SC, Breder V, Ostapenko Y, Reig M, Makowsky M, Paskow MJ, Gupta C, Kurland JF, Negro A, Abou-Alfa GK; HIMALAYA investigators. Sangro B, et al. Ann Oncol. 2024 May;35(5):448-457. doi: 10.1016/j.annonc.2024.02.005. Epub 2024 Feb 19. Ann Oncol. 2024. PMID: 38382875 Free article. Clinical Trial.
TRP Channels in Brain Tumors.
Chinigò G, Castel H, Chever O, Gkika D. Chinigò G, et al. Among authors: castel h. Front Cell Dev Biol. 2021 Apr 13;9:617801. doi: 10.3389/fcell.2021.617801. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33928077 Free PMC article. Review.
Neuroprotection with the Endozepine Octadecaneuropeptide, ODN.
Masmoudi-Kouki O, Hamdi Y, Ghouili I, Bahdoudi S, Kaddour H, Leprince J, Castel H, Vaudry H, Amri M, Vaudry D, Tonon MC. Masmoudi-Kouki O, et al. Among authors: castel h. Curr Pharm Des. 2018;24(33):3918-3925. doi: 10.2174/1381612824666181112111746. Curr Pharm Des. 2018. PMID: 30417780 Review.
Challenges in glioblastoma research: focus on the tumor microenvironment: (Trends in Cancer, 9:1 p:9-27, 2023).
Bikfalvi A, da Costa CA, Avril T, Barnier JV, Bauchet L, Brisson L, Cartron PF, Castel H, Chevet E, Chneiweiss H, Clavreul A, Constantin B, Coronas V, Daubon T, Dontenwill M, Ducray F, Entz-Werlé N, Figarella-Branger D, Fournier I, Frenel JS, Gabut M, Galli T, Gavard J, Huberfeld G, Hugnot JP, Idbaih A, Junier MP, Mathivet T, Menei P, Meyronet D, Mirjolet C, Morin F, Mosser J, Moyal EC, Rousseau V, Salzet M, Sanson M, Seano G, Tabouret E, Tchoghandjian A, Turchi L, Vallette FM, Vats S, Verreault M, Virolle T. Bikfalvi A, et al. Among authors: castel h. Trends Cancer. 2023 Aug;9(8):692. doi: 10.1016/j.trecan.2023.02.006. Epub 2023 Mar 28. Trends Cancer. 2023. PMID: 36997420 No abstract available.
Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe.
European Cancer and Cognition Consortium (ECCC); Sleurs C, Amidi A, Wu LM, Kiesl D, Zimmer P, Lange M, Rogiers A, Giffard B, Binarelli G, Borghgraef C, Deprez S, Duivon M, De Ruiter M, Schagen S, Ahmed-Lecheheb D, Castel H, Buskbjerg CR, Dos Santos M, Joly F, Perrier J. European Cancer and Cognition Consortium (ECCC), et al. Among authors: castel h. Crit Rev Oncol Hematol. 2022 Dec;180:103859. doi: 10.1016/j.critrevonc.2022.103859. Epub 2022 Oct 17. Crit Rev Oncol Hematol. 2022. PMID: 36257539 Free article. Review.
Hypothalamic glucose-sensing: role of Glia-to-neuron signaling.
Tonon MC, Lanfray D, Castel H, Vaudry H, Morin F. Tonon MC, et al. Among authors: castel h. Horm Metab Res. 2013 Dec;45(13):955-9. doi: 10.1055/s-0033-1355357. Epub 2013 Sep 23. Horm Metab Res. 2013. PMID: 24062091 Review.
150 results